2017
DOI: 10.1007/s10517-017-3925-5
|View full text |Cite
|
Sign up to set email alerts
|

Oligonucleotide Microchip for the Identification of Infectious Agents of Reproductive System with Simultaneous Analysis of Determinants of Resistance to Antimicrobial Substances

Abstract: We developed a multiplexed DNA microarray-based assay allowing identification of 12 causative agents of reproductive tract infections with the simultaneous detection of 47 genetic determinants of resistance to antimicrobial substances. The microarray was tested on 93 isolates of Neisseria gonorrhoeae, 32 isolates of Treponema pallidum and 29 samples of Ureaplasma spp./Mycoplasma spp. The N. gonorrhoeae isolates had multiple mutations in the penA, ponA, rpsJ, gyrA, parC, and mtrR genes; their prognostic value s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 10 publications
0
9
0
1
Order By: Relevance
“…The microarray was previously developed for the identification of causative agents of human reproductive tract infections, including N . gonorrhoeae , and for the simultaneous detection of genetic markers of resistance to different antimicrobial drugs [36]. The microarray consisted of elements with immobilized oligonucleotides for the detection of different mutations and other determinants associated with resistance to beta-lactams: mutations in penA resulting in the insertion of Asp in the 345 position in PBP2 (insAsp345), mutations in ponA resulting in the amino acid substitution Leu421Pro in PBP1, the bla TEM plasmid and Met182Thr and Gly238Ser substitutions in the gene encoding beta-lactamase, mutations in porB leading to the amino acid changes Gly120Lys/Asp/Asn/Thr and Ala121/Asp/Asn/Gly/Ser in the porin protein, and deletion A (delA) and insertions T and TT (insT and insTT) in the promoter region of mtrR .…”
Section: Methodsmentioning
confidence: 99%
“…The microarray was previously developed for the identification of causative agents of human reproductive tract infections, including N . gonorrhoeae , and for the simultaneous detection of genetic markers of resistance to different antimicrobial drugs [36]. The microarray consisted of elements with immobilized oligonucleotides for the detection of different mutations and other determinants associated with resistance to beta-lactams: mutations in penA resulting in the insertion of Asp in the 345 position in PBP2 (insAsp345), mutations in ponA resulting in the amino acid substitution Leu421Pro in PBP1, the bla TEM plasmid and Met182Thr and Gly238Ser substitutions in the gene encoding beta-lactamase, mutations in porB leading to the amino acid changes Gly120Lys/Asp/Asn/Thr and Ala121/Asp/Asn/Gly/Ser in the porin protein, and deletion A (delA) and insertions T and TT (insT and insTT) in the promoter region of mtrR .…”
Section: Methodsmentioning
confidence: 99%
“…Genetic determinants of antimicrobial resistance were identified using an oligonucleotide hydrogel-based low-density microarray as described previously [ 34 , 35 ]. The analyzed determinants associated with resistance to penicillin G [ 12 , 23 ] were as follows: mutations in the ponA gene resulting in the amino acid substitution Leu421Pro in penicillin-binding protein 1 (PBP1), mutations in the penA gene resulting in the insertion of an aspartate in the 345 position (insAsp345a) of PBP2, and the presence of bla TEM plasmids encoding β-lactamases capable of hydrolyzing amide bonds in penicillins.…”
Section: Methodsmentioning
confidence: 99%
“…A microarray ( Fig. 5A ) and a procedure for its use have been developed to identify the DNAs of 12 different obligate and opportunistic microorganisms and simultaneously perform the differential analysis of 39 genetic determinants of resistance to β-lactam antibiotics, macrolides, aminoglycosides, tetracycline, spectinomycin, fluoroquinolones, and nitroimidazole [33].…”
Section: Analysis Of Specific Sequences Of Bacterial and Viral Genomesmentioning
confidence: 99%